Nephritis News and Research

RSS
Nephritis is the general term used to describe inflammation of the glomerulus, tubules or interstitial tissue in the kidneys. The condition affects functioning of the kidney and its ability to filter blood and excrete waste products via the urine.
USPTO grants Taligen patent for TT30 lead product candidate

USPTO grants Taligen patent for TT30 lead product candidate

Systemic lupus erythematosus drug market to quadruple from $400 million in 2009 to over $1.6 billion in 2019

Systemic lupus erythematosus drug market to quadruple from $400 million in 2009 to over $1.6 billion in 2019

PIKAMAB secures exclusive rights to issued U.S. patent from UABRF

PIKAMAB secures exclusive rights to issued U.S. patent from UABRF

LFA seeks grant applications from medical researchers to help advance understanding of lupus nephritis

LFA seeks grant applications from medical researchers to help advance understanding of lupus nephritis

Increase in anti-Apo A-I, anti-HDL and anti-CRP may lead to atherosclerosis in SLE patients

Increase in anti-Apo A-I, anti-HDL and anti-CRP may lead to atherosclerosis in SLE patients

Investigators identify new disease mechanism and therapeutic approach for lupus kidney disease

Investigators identify new disease mechanism and therapeutic approach for lupus kidney disease

LRI awards $3.6 million grants to drive innovative science in lupus and related diseases

LRI awards $3.6 million grants to drive innovative science in lupus and related diseases

Lupus patients rarely develop kidney disorders after a kidney transplant

Lupus patients rarely develop kidney disorders after a kidney transplant

PIKAMAB obtains U.S. patent rights to develop theragnostic product

PIKAMAB obtains U.S. patent rights to develop theragnostic product

Mycophenolate mofetil may be an alternative therapy for lupus nephritis

Mycophenolate mofetil may be an alternative therapy for lupus nephritis

Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint

Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint

Rituximab reduces kidney inflammation in patients with severe lupus nephritis

Rituximab reduces kidney inflammation in patients with severe lupus nephritis

Variations of MYH9 gene help explain high rate of kidney disease in African Americans

Variations of MYH9 gene help explain high rate of kidney disease in African Americans

Lupus more severe in patients with ancestry from southern Europe

Lupus more severe in patients with ancestry from southern Europe

Cellcept immunosuppressant further linked to birth defects

Cellcept immunosuppressant further linked to birth defects

Methods for treating lupus nephritis

Methods for treating lupus nephritis

Women suffering lupus OK to take oral contraceptives

Women suffering lupus OK to take oral contraceptives

Mycophenolate mofetil helps treat lupus patients

Mycophenolate mofetil helps treat lupus patients

Suitcase-sized machine helps patients undergoing rigorous dialysis for kidney failure

Suitcase-sized machine helps patients undergoing rigorous dialysis for kidney failure

Up to 500,000 Americans will develop lupus-related kidney disease

Up to 500,000 Americans will develop lupus-related kidney disease